How do I calculate the epinephrine dose for a 120‑kg adult with refractory anaphylaxis?

Epinephrine Dosing for a 120-kg Adult with Refractory Anaphylaxis

For a 120-kg adult with refractory anaphylaxis, administer 0.5 mg (0.5 mL of 1:1000) epinephrine intramuscularly into the anterolateral thigh every 5 minutes until symptoms resolve, with no maximum number of doses—most patients require 1-2 doses, but continue as clinically needed. 1, 2, 3

Initial Intramuscular Dosing

• The standard adult dose is 0.3–0.5 mg (1:1000 dilution) intramuscularly, with the FDA-approved maximum single dose capped at 0.5 mg regardless of body weight, as higher doses increase cardiac adverse effects without improving outcomes. 1, 2, 3

• For this 120-kg patient, use the maximum 0.5 mg dose rather than weight-based dosing (which would calculate to 1.2 mg using 0.01 mg/kg), because the safety ceiling is 0.5 mg per injection. 2, 3

• Inject into the anterolateral aspect of the mid-thigh (vastus lateralis), which achieves peak plasma concentrations in 8±2 minutes compared to 34±14 minutes with subcutaneous deltoid injection. 2, 4, 5

Repeat Dosing Protocol

• Repeat 0.5 mg intramuscularly every 5 minutes if symptoms persist or worsen—there is no maximum number of doses, and clinical response determines when to stop. 1, 2

• Approximately 10–28% of patients require a second dose, and some need more than two doses before symptom recovery. 2, 6

• Delayed epinephrine administration is associated with fatalities, not multiple doses—continue dosing every 5 minutes until hypotension, airway swelling, or respiratory distress resolves. 1, 2, 5

Escalation to Intravenous Epinephrine for Refractory Shock

If the patient remains hypotensive despite 2–3 intramuscular doses (total 1.0–1.5 mg) and aggressive crystalloid resuscitation (1–2 L bolus), transition to intravenous epinephrine:

• IV bolus dosing: Administer 0.05–0.1 mg (50–100 mcg) of 1:10,000 epinephrine slowly, repeated as needed. 1, 2

• IV infusion: Start at 5–15 mcg/min and titrate to blood pressure response, with a maximum rate of 10 mcg/min. 1, 2

• Preparation: Add 1 mg (1 mL of 1:1000) epinephrine to 250 mL D5W to yield 4 mcg/mL concentration. 2, 6

• Critical safety point: IV epinephrine requires continuous cardiac monitoring because of the risk of arrhythmias and hypertensive crisis—the intramuscular route is safer for initial treatment. 1, 2, 6

Concurrent Resuscitation Measures

• Aggressive fluid resuscitation is mandatory: Administer 1–2 L of normal saline or lactated Ringer's rapidly through large-bore IV access to counter massive capillary leak. 1, 2

• Position the patient supine with legs elevated unless severe respiratory distress is present, in which case allow the patient to sit upright. 2

• Provide 100% supplemental oxygen and prepare for advanced airway management, as oropharyngeal or laryngeal edema can develop rapidly and may require emergency cricothyroidotomy. 1, 2

• Close hemodynamic monitoring is essential because cardiovascular and respiratory status can deteriorate quickly. 1, 2

Adjunctive Therapies (Second-Line Only)

• H1-antihistamine: Diphenhydramine 25–50 mg IV/IM. 1, 2

• H2-antihistamine: Ranitidine 50 mg IV (or famotidine 20 mg IV if ranitidine unavailable), as the combination of H1 + H2 antagonists is superior to H1 alone. 1, 2

• Corticosteroids: Methylprednisolone 1–2 mg/kg IV every 6 hours (approximately 120–240 mg for this patient) to prevent biphasic reactions, though they provide no acute benefit and must never delay epinephrine. 1, 2

• For persistent bronchospasm: Nebulized albuterol 2.5–5 mg in 3 mL saline if wheezing is unresponsive to epinephrine. 1, 2

Special Consideration: Beta-Blocker Therapy

If the patient is on beta-blockers and remains hypotensive after 2–3 doses of intramuscular epinephrine and adequate fluid resuscitation:

• Administer glucagon 1–5 mg IV over 5 minutes, followed by an infusion of 5–15 mcg/min, as glucagon exerts positive inotropic effects via non-β-adrenergic pathways. 1, 2

• Glucagon can cause nausea and vomiting—position the patient to protect the airway during administration. 1, 2

Common Pitfalls to Avoid

• Do not use weight-based dosing that exceeds 0.5 mg for a single intramuscular injection—the 120-kg weight does not justify exceeding the safety ceiling. 2, 3

• Do not confuse epinephrine concentrations: Always use 1:1000 (1 mg/mL) for intramuscular injection; 1:10,000 (0.1 mg/mL) is reserved exclusively for IV use. 1, 2, 3

• Do not stop at one dose prematurely—if symptoms persist or progress after 5 minutes, immediately administer the second dose. 2, 5

• Do not delay epinephrine for antihistamines or corticosteroids—epinephrine is the only medication proven to prevent death from anaphylaxis. 1, 2, 5

Observation and Discharge

• Observe for a minimum of 4–6 hours after symptom resolution, with longer observation (up to 24 hours) warranted for severe reactions, persistent airway symptoms, or when multiple epinephrine doses were required, as biphasic reactions occur in 7–18% of cases. 2

• Prescribe two epinephrine autoinjectors (0.3 mg) with hands-on training and a written anaphylaxis action plan. 2, 6

• Arrange follow-up with an allergist-immunologist within 1–2 weeks for formal allergy testing and long-term management. 2, 6